North America Radiation Oncology Market Size & Outlook
North America radiation oncology market, 2017-2028 (US$M)
Related Markets
North America radiation oncology market highlights
- The North America radiation oncology market generated a revenue of USD 3,448.2 million in 2020.
- The market is expected to grow at a CAGR of 7.4% from 2021 to 2028.
- In terms of segment, external beam radiationtherapy was the largest revenue generating type in 2020.
- Internal Beam Radiation Therapy is the most lucrative type segment registering the fastest growth during the forecast period.
- Country-wise, Canada is expected to register the highest CAGR from 2021 to 2028.
North America data book summary
| Market revenue in 2020 | USD 3,448.2 million |
| Market revenue in 2028 | USD 6,097.0 million |
| Growth rate | 7.4% (CAGR from 2020 to 2028) |
| Largest segment | External beam radiationtherapy |
| Fastest growing segment | Internal Beam Radiation Therapy |
| Historical data covered | 2017 - 2019 |
| Base year for estimation | 2020 |
| Forecast period covered | 2021 - 2028 |
| Quantitative units | Revenue in USD million |
| Market segmentation | External Beam RadiationTherapy, Internal Beam Radiation Therapy |
| Key market players worldwide | Siemens Healthineers AG ADR, Elekta AB ADR, BD, Accuray Inc, IBA RadioPharma Solutions, IsoRay, MeVis Medical Solutions AG, Nordion, Ntp Radioisotopes, Curium Pharma, ViewRay |
Other key industry trends
- In terms of revenue, North America region accounted for 45.5% of the global radiation oncology market in 2020.
- Globally, North America is projected to lead the regional market in terms of revenue in 2028.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 2,803.8 million by 2028.
External beam radiationtherapy was the largest segment with a revenue share of 66.91% in 2020. Horizon Databook has segmented the North America radiation oncology market based on external beam radiationtherapy, internal beam radiation therapy covering the revenue growth of each sub-segment from 2017 to 2028.
North America radiation oncology market is expected to be driven by factors such as rising incidence of cancer, growing geriatric population, high healthcare expenditure, and supportive government funding. In addition, presence of organizations such as the American Society for Radiation Oncology (ASTRO), world’s largest radiation oncology society with over 10,000 members including radiation therapists.
Biologists, nurses, physicians, and other healthcare professionals is anticipated to further propel the market growth. The society aims to improve patient care through training and education. It also promotes continuous cancer research and new approaches involved in radiation treatment and encourages adoption of radiation oncology.
In addition, favorable regulatory policies and increasing investments by pharmaceutical companies are expected to further boost market growth. Governments in North American countries are focusing on increasing the production of medical isotopes and therefore.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Radiation Oncology Market Scope
Radiation Oncology Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
North America radiation oncology market size, by country, 2017-2028 (US$M)
North America Radiation Oncology Market Outlook Share, 2020 & 2028 (US$M)
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
